Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.

<h4>Background</h4>Probiotics are proposed to positively modulate the intestinal epithelial barrier formed by intestinal epithelial cells (IECs) and intercellular junctions. Disruption of this border alters paracellular permeability and is a key mechanism for the development of enteric i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sya N Ukena, Anurag Singh, Ulrike Dringenberg, Regina Engelhardt, Ursula Seidler, Wiebke Hansen, André Bleich, Dunja Bruder, Anke Franzke, Gerhard Rogler, Sebastian Suerbaum, Jan Buer, Florian Gunzer, Astrid M Westendorf
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2007
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9d49b6f3f0d641289e56b96d8afc9204
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9d49b6f3f0d641289e56b96d8afc9204
record_format dspace
spelling oai:doaj.org-article:9d49b6f3f0d641289e56b96d8afc92042021-11-25T06:13:41ZProbiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.1932-620310.1371/journal.pone.0001308https://doaj.org/article/9d49b6f3f0d641289e56b96d8afc92042007-12-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0001308https://doaj.org/toc/1932-6203<h4>Background</h4>Probiotics are proposed to positively modulate the intestinal epithelial barrier formed by intestinal epithelial cells (IECs) and intercellular junctions. Disruption of this border alters paracellular permeability and is a key mechanism for the development of enteric infections and inflammatory bowel diseases (IBDs).<h4>Methodology and principal findings</h4>To study the in vivo effect of probiotic Escherichia coli Nissle 1917 (EcN) on the stabilization of the intestinal barrier under healthy conditions, germfree mice were colonized with EcN or K12 E. coli strain MG1655. IECs were isolated and analyzed for gene and protein expression of the tight junction molecules ZO-1 and ZO-2. Then, in order to analyze beneficial effects of EcN under inflammatory conditions, the probiotic was orally administered to BALB/c mice with acute dextran sodium sulfate (DSS) induced colitis. Colonization of gnotobiotic mice with EcN resulted in an up-regulation of ZO-1 in IECs at both mRNA and protein levels. EcN administration to DSS-treated mice reduced the loss of body weight and colon shortening. In addition, infiltration of the colon with leukocytes was ameliorated in EcN inoculated mice. Acute DSS colitis did not result in an anion secretory defect, but abrogated the sodium absorptive function of the mucosa. Additionally, intestinal barrier function was severely affected as evidenced by a strong increase in the mucosal uptake of Evans blue in vivo. Concomitant administration of EcN to DSS treated animals resulted in a significant protection against intestinal barrier dysfunction and IECs isolated from these mice exhibited a more pronounced expression of ZO-1.<h4>Conclusion and significance</h4>This study convincingly demonstrates that probiotic EcN is able to mediate up-regulation of ZO-1 expression in murine IECs and confer protection from the DSS colitis-associated increase in mucosal permeability to luminal substances.Sya N UkenaAnurag SinghUlrike DringenbergRegina EngelhardtUrsula SeidlerWiebke HansenAndré BleichDunja BruderAnke FranzkeGerhard RoglerSebastian SuerbaumJan BuerFlorian GunzerAstrid M WestendorfPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 2, Iss 12, p e1308 (2007)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sya N Ukena
Anurag Singh
Ulrike Dringenberg
Regina Engelhardt
Ursula Seidler
Wiebke Hansen
André Bleich
Dunja Bruder
Anke Franzke
Gerhard Rogler
Sebastian Suerbaum
Jan Buer
Florian Gunzer
Astrid M Westendorf
Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
description <h4>Background</h4>Probiotics are proposed to positively modulate the intestinal epithelial barrier formed by intestinal epithelial cells (IECs) and intercellular junctions. Disruption of this border alters paracellular permeability and is a key mechanism for the development of enteric infections and inflammatory bowel diseases (IBDs).<h4>Methodology and principal findings</h4>To study the in vivo effect of probiotic Escherichia coli Nissle 1917 (EcN) on the stabilization of the intestinal barrier under healthy conditions, germfree mice were colonized with EcN or K12 E. coli strain MG1655. IECs were isolated and analyzed for gene and protein expression of the tight junction molecules ZO-1 and ZO-2. Then, in order to analyze beneficial effects of EcN under inflammatory conditions, the probiotic was orally administered to BALB/c mice with acute dextran sodium sulfate (DSS) induced colitis. Colonization of gnotobiotic mice with EcN resulted in an up-regulation of ZO-1 in IECs at both mRNA and protein levels. EcN administration to DSS-treated mice reduced the loss of body weight and colon shortening. In addition, infiltration of the colon with leukocytes was ameliorated in EcN inoculated mice. Acute DSS colitis did not result in an anion secretory defect, but abrogated the sodium absorptive function of the mucosa. Additionally, intestinal barrier function was severely affected as evidenced by a strong increase in the mucosal uptake of Evans blue in vivo. Concomitant administration of EcN to DSS treated animals resulted in a significant protection against intestinal barrier dysfunction and IECs isolated from these mice exhibited a more pronounced expression of ZO-1.<h4>Conclusion and significance</h4>This study convincingly demonstrates that probiotic EcN is able to mediate up-regulation of ZO-1 expression in murine IECs and confer protection from the DSS colitis-associated increase in mucosal permeability to luminal substances.
format article
author Sya N Ukena
Anurag Singh
Ulrike Dringenberg
Regina Engelhardt
Ursula Seidler
Wiebke Hansen
André Bleich
Dunja Bruder
Anke Franzke
Gerhard Rogler
Sebastian Suerbaum
Jan Buer
Florian Gunzer
Astrid M Westendorf
author_facet Sya N Ukena
Anurag Singh
Ulrike Dringenberg
Regina Engelhardt
Ursula Seidler
Wiebke Hansen
André Bleich
Dunja Bruder
Anke Franzke
Gerhard Rogler
Sebastian Suerbaum
Jan Buer
Florian Gunzer
Astrid M Westendorf
author_sort Sya N Ukena
title Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
title_short Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
title_full Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
title_fullStr Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
title_full_unstemmed Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
title_sort probiotic escherichia coli nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
publisher Public Library of Science (PLoS)
publishDate 2007
url https://doaj.org/article/9d49b6f3f0d641289e56b96d8afc9204
work_keys_str_mv AT syanukena probioticescherichiacolinissle1917inhibitsleakygutbyenhancingmucosalintegrity
AT anuragsingh probioticescherichiacolinissle1917inhibitsleakygutbyenhancingmucosalintegrity
AT ulrikedringenberg probioticescherichiacolinissle1917inhibitsleakygutbyenhancingmucosalintegrity
AT reginaengelhardt probioticescherichiacolinissle1917inhibitsleakygutbyenhancingmucosalintegrity
AT ursulaseidler probioticescherichiacolinissle1917inhibitsleakygutbyenhancingmucosalintegrity
AT wiebkehansen probioticescherichiacolinissle1917inhibitsleakygutbyenhancingmucosalintegrity
AT andrebleich probioticescherichiacolinissle1917inhibitsleakygutbyenhancingmucosalintegrity
AT dunjabruder probioticescherichiacolinissle1917inhibitsleakygutbyenhancingmucosalintegrity
AT ankefranzke probioticescherichiacolinissle1917inhibitsleakygutbyenhancingmucosalintegrity
AT gerhardrogler probioticescherichiacolinissle1917inhibitsleakygutbyenhancingmucosalintegrity
AT sebastiansuerbaum probioticescherichiacolinissle1917inhibitsleakygutbyenhancingmucosalintegrity
AT janbuer probioticescherichiacolinissle1917inhibitsleakygutbyenhancingmucosalintegrity
AT floriangunzer probioticescherichiacolinissle1917inhibitsleakygutbyenhancingmucosalintegrity
AT astridmwestendorf probioticescherichiacolinissle1917inhibitsleakygutbyenhancingmucosalintegrity
_version_ 1718413999777775616